Poststroke Hip Fracture: Prevalence, Clinical Characteristics, Mineral-Bone Metabolism, Outcomes, and Gaps in Prevention

Table 2

Haematologic, renal, liver, and thyroid parameters in older hip fracture patients with and without history of stroke.

Characteristics	HF poststroke	HF without history of stroke	𝑃 value
Erythrocyte count, ×10^12/L	4.21±0.61	4.08±0.61	0.217
Haemoglobin, g/L	126.0±18.9	124.7±16.9	0.601
Leukocyte count, ×10^9/L	12.0±4.22	10.5±4.24	0.034
Lymphocyte count, ×10^9/L	1.24±1.39	1.31±1.22	0.742
MCV, fl	87.4±16.5	90.8±5.98	0.019
MCH, pg/cell	30.3±3.35	30.7±2.29	0.290
MCHC, g/L	338.0±19.4	340.7±37.1	0.660
RDW, %	15.1±2.05	15.2±9.53	0.942
Iron, 𝜇mol/L	4.81±4.12	5.33±4.39	0.507
Transferrin, g/L	1.68±0.49	1.72±0.48	0.582
Transferrin saturation, %	11.08±10.07	11.65±8.36	0.716
Ferritin, mg/L	313.1±244.9	298.9±283.3	0.778
Vitamin B12, pmol/L	482.6±321.0	376.0±256.0	0.027
Folic acid (serum), nmol/L	25.2±16.7	26.1±15.4	0.747
Urea, mmol/L	7.9±4.30	7.8±3.67	08.37
Creatinine, mmol/L	92.0±43.86	93.6±57.24	0.873
eGFR, mL/min/1.73 m^2	62.5±25.2	64.9±23.2	0.561
Albumin, g/L	36.6±6.0	37.0±6.4	0.723
Bilirubin, 𝜇mol/L	13.0±5.95	12.2±7.62	0.503
ALT, U/L	20.4±12.8	21.4±22.3	0.801
ALP, U/L	103.8±44.3	105.9±85.8	0.882
GGT, U/L	55.8±90.5	54.3±98.6	0.928
TSH, µU/L	1.25±1.47	1.60±2.31	0.361
T4, pmol/L	16.02±3.61	15.98±3.54	0.949
CRP, mg/L	137.1±76.7	129.2±83.1	0.583

The values are expressed as mean ± standard deviation (SD). HF: hip fracture; MCV: mean corpuscular volume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; RDW: red-cell distribution width; eGFR: estimated glomerular filtration rate; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGT: gamma glutamyltransferase; TSH: thyroid-stimulating hormone; T₄: total thyroxin.